Nanexa AB
- Address
- Virdings Alle 2, Vaksala
Sponsor Overview
Specializations
Type 2 diabetes
Nanexa AB’s clinical research is centered on type 2 diabetes, with attention to metabolic disease and the development of therapies intended for people living with impaired glucose regulation.
- Glycaemic control
- Metabolic disorder
- Diabetes pharmacology
The sponsor’s activity in this area reflects an interest in advancing therapeutic options for diabetes mellitus through focused clinical investigation.
Pharmacokinetics
Research activity also includes pharmacokinetic evaluation, supporting the assessment of how investigational treatments are processed in the body in people with type 2 diabetes.
- Drug absorption
- Drug distribution
- Drug metabolism
This area of interest is relevant to understanding the behavior of emerging antidiabetic therapies in a clinical setting.
Endocrinology
The sponsor’s clinical portfolio aligns with endocrinology, particularly conditions involving insulin resistance and dysregulated glucose homeostasis.
- Hormonal regulation
- Pancreatic function
- Glucose homeostasis
These interests place emphasis on therapeutic development within the broader field of metabolic endocrinology.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase 1 Study to Evaluate the Pharmacokinetics of NEX-22A in Subjects with Type 2 Diabetes Mellitus |  Germany | Not Recruiting |
| Pharmacokinetic Evaluation of NEX-22A in Patients with Type 2 Diabetes: A Phase 1 Clinical Trial | Germany | Not Yet Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Nutritional and Metabolic Diseases2 trials211 other sponsors
Partnered Research Centres
1 centre- Address
- Hellersbergstrasse 9, Hammfeld, 41460 Neuss
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Nanexa AB.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.